Renaissance Technologies’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.52M | Sell |
334,525
-28,483
| -8% | -$214K | ﹤0.01% | 1970 |
|
|
2025
Q1 | $2.75M | Buy |
363,008
+172,500
| +91% | +$1.31M | ﹤0.01% | 1796 |
|
|
2024
Q4 | $2.32M | Sell |
190,508
-91,292
| -32% | -$1.11M | ﹤0.01% | 1962 |
|
|
2024
Q3 | $4.72M | Sell |
281,800
-139,908
| -33% | -$2.34M | 0.01% | 1474 |
|
|
2024
Q2 | $7.35M | Buy |
421,708
+100,608
| +31% | +$1.75M | 0.01% | 1090 |
|
|
2024
Q1 | $5.47M | Buy |
321,100
+57,012
| +22% | +$972K | 0.01% | 1363 |
|
|
2023
Q4 | $2.69M | Buy |
264,088
+41,388
| +19% | +$422K | ﹤0.01% | 1756 |
|
|
2023
Q3 | $2.02M | Sell |
222,700
-22,900
| -9% | -$207K | ﹤0.01% | 1858 |
|
|
2023
Q2 | $2.64M | Buy |
245,600
+6,400
| +3% | +$68.9K | ﹤0.01% | 1822 |
|
|
2023
Q1 | $2.45M | Sell |
239,200
-68,500
| -22% | -$701K | ﹤0.01% | 1897 |
|
|
2022
Q4 | $3.25M | Buy |
307,700
+5,505
| +2% | +$58.1K | ﹤0.01% | 1763 |
|
|
2022
Q3 | $3.87M | Buy |
302,195
+8,595
| +3% | +$110K | 0.01% | 1596 |
|
|
2022
Q2 | $3.76M | Buy |
+293,600
| New | +$3.76M | ﹤0.01% | 1762 |
|
|
2022
Q1 | – | Sell |
-26,600
| Closed | -$410K | – | 4104 |
|
|
2021
Q4 | $410K | Buy |
+26,600
| New | +$410K | ﹤0.01% | 3174 |
|
|
2021
Q3 | – | Sell |
-25,982
| Closed | -$669K | – | 3512 |
|
|
2021
Q2 | $669K | Buy |
+25,982
| New | +$669K | ﹤0.01% | 2843 |
|